Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Birth control pills can help reduce mild to moderate acne in women.

Treat pattern hair loss with finasteride and topical minoxidil.